Subject: HIV vaccine research takes new direction

HIV vaccine research takes new direction

United Press International - November 11, 2009

http://www.aegis.org/news/upi/2009/UP091106.html

DURHAM, N.C., Nov. 11 (UPI) -- U.S. scientists seeking a vaccine for the human immunodeficiency virus say a study of HIV antibodies is leading them in a new direction.

The Duke University Medical Center-led researchers said that new direction came from a detailed study of how the most robust antibodies work to block the HIV as it seeks entry into healthy cells.

"Our study clearly showed that we've been overlooking a very important component of antibody function," said S. Munir Alam, associate professor of medicine and lead author of the study.

Alam and Harvard Medical School Assistant Professor Bing Chen said they studied two potentially powerful antibodies against HIV, 2F5 and 4E10. Both of are rare, broadly neutralizing antibodies, meaning they can block a number of strains of HIV, the scientists said.

The researchers found successful docking of the antibody to the HIV outer coat membrane region required antibody attachment to the virus's membrane, which contains lipid.

"This two-step mechanism, not previously appreciated, might extend to antibodies that protect against other viruses," said study co-author Stephen Harrison of Harvard Medical School.

The researchers said they are now designing a vaccine that incorporates a lipid component and design trials are now being conducted on animals.

The findings are detailed in the Proceedings of the National Academy of Sciences.

091111
UP091106

Copyright ? 2009 - United Press International. All rights reserved. Reproduced with permission. Reproduction of this article (other than one copy for personal reference) must be cleared through United Press International, Permissions Desk, 1510 H St. N.W. Washington DC 2005. Main Phone Switchboard: 202-898-8000 FAX: 202-898-8057 or 202-898-8147 Email: info@upi.com.

AEGiS is a 501(c)3, not-for-profit, tax-exempt, educational corporation. AEGiS is made possible through unrestricted funding from the Elton John AIDS Foundation, National Library of Medicine, AIDS Walk of Orange County, and donations from users like you.

Always watch for outdated information. This article first appeared in 2009. This material is designed to support, not replace, the relationship that exists between you and your doctor.

AEGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is often presented in summary or aggregate form. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.

Copyright ?1980, 2009. AEGiS. All materials appearing on AEGiS are protected by copyright as a collective work or compilation under U.S. copyright and other laws and are the property of AEGiS, or the party credited as the provider of the content.